ARMP — Armata Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapMomentum Trap

Annual balance sheet for Armata Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	9.65	10.3	14.9	13.5	9.29
Net Total Receivables	—	—	—	3.36	0.744
Prepaid Expenses
Total Other Current Assets
Total Current Assets	10.8	15	27	19.2	11.3
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	12.8	38.1	46.7	57.3	54.9
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	39.5	69.8	95.8	98.4	86.4
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	6.71	4.81	24.9	16.5	48.2
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	20.7	44.4	59.8	130	134
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	18.9	25.4	36.1	-32.1	-48
Total Liabilities & Shareholders' Equity	39.5	69.8	95.8	98.4	86.4
Total Common Shares Outstanding